vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and GCM Grosvenor Inc. (GCMG). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $177.1M, roughly 1.3× GCM Grosvenor Inc.). GCM Grosvenor Inc. runs the higher net margin — 32.8% vs -35.0%, a 67.9% gap on every dollar of revenue. On growth, GCM Grosvenor Inc. posted the faster year-over-year revenue change (7.2% vs -23.6%). GCM Grosvenor Inc. produced more free cash flow last quarter ($175.0M vs $16.1M). Over the past eight quarters, GCM Grosvenor Inc.'s revenue compounded faster (27.5% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.
CCRN vs GCMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $177.1M |
| Net Profit | $-82.9M | $58.2M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 30.9% |
| Net Margin | -35.0% | 32.8% |
| Revenue YoY | -23.6% | 7.2% |
| Net Profit YoY | -2109.7% | 149.2% |
| EPS (diluted) | $-2.56 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $177.1M | ||
| Q3 25 | $250.1M | $135.0M | ||
| Q2 25 | $274.1M | $119.7M | ||
| Q1 25 | $293.4M | $125.8M | ||
| Q4 24 | $309.9M | $165.3M | ||
| Q3 24 | $315.1M | $122.9M | ||
| Q2 24 | $339.8M | $117.0M | ||
| Q1 24 | $379.2M | $108.9M |
| Q4 25 | $-82.9M | $58.2M | ||
| Q3 25 | $-4.8M | $10.5M | ||
| Q2 25 | $-6.7M | $15.4M | ||
| Q1 25 | $-490.0K | $463.0K | ||
| Q4 24 | $-3.8M | $7.6M | ||
| Q3 24 | $2.6M | $4.2M | ||
| Q2 24 | $-16.1M | $4.8M | ||
| Q1 24 | $2.7M | $2.1M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | 30.9% | ||
| Q3 25 | -2.4% | 32.7% | ||
| Q2 25 | -2.1% | 16.1% | ||
| Q1 25 | -0.3% | 12.2% | ||
| Q4 24 | -1.1% | 26.4% | ||
| Q3 24 | 0.9% | 20.3% | ||
| Q2 24 | -5.7% | 17.8% | ||
| Q1 24 | 0.8% | -14.7% |
| Q4 25 | -35.0% | 32.8% | ||
| Q3 25 | -1.9% | 7.8% | ||
| Q2 25 | -2.4% | 12.9% | ||
| Q1 25 | -0.2% | 0.4% | ||
| Q4 24 | -1.2% | 4.6% | ||
| Q3 24 | 0.8% | 3.4% | ||
| Q2 24 | -4.7% | 4.1% | ||
| Q1 24 | 0.7% | 2.0% |
| Q4 25 | $-2.56 | $0.23 | ||
| Q3 25 | $-0.15 | $0.16 | ||
| Q2 25 | $-0.20 | $0.05 | ||
| Q1 25 | $-0.02 | $-0.02 | ||
| Q4 24 | $-0.13 | $0.09 | ||
| Q3 24 | $0.08 | $0.03 | ||
| Q2 24 | $-0.47 | $0.04 | ||
| Q1 24 | $0.08 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $242.1M |
| Total DebtLower is stronger | — | $428.4M |
| Stockholders' EquityBook value | $322.8M | $27.0M |
| Total Assets | $449.0M | $813.8M |
| Debt / EquityLower = less leverage | — | 15.87× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $242.1M | ||
| Q3 25 | $99.1M | $182.7M | ||
| Q2 25 | $81.2M | $136.3M | ||
| Q1 25 | $80.7M | $94.5M | ||
| Q4 24 | $81.6M | $89.5M | ||
| Q3 24 | $64.0M | $98.4M | ||
| Q2 24 | $69.6M | $73.9M | ||
| Q1 24 | $5.2M | $41.9M |
| Q4 25 | — | $428.4M | ||
| Q3 25 | — | $429.3M | ||
| Q2 25 | — | $430.2M | ||
| Q1 25 | — | $431.1M | ||
| Q4 24 | — | $432.0M | ||
| Q3 24 | — | $432.9M | ||
| Q2 24 | — | $433.8M | ||
| Q1 24 | — | $384.0M |
| Q4 25 | $322.8M | $27.0M | ||
| Q3 25 | $408.1M | $-7.4M | ||
| Q2 25 | $412.2M | $-12.3M | ||
| Q1 25 | $418.2M | $-28.3M | ||
| Q4 24 | $419.0M | $-27.6M | ||
| Q3 24 | $424.7M | $-31.9M | ||
| Q2 24 | $433.3M | $-28.5M | ||
| Q1 24 | $462.4M | $-26.4M |
| Q4 25 | $449.0M | $813.8M | ||
| Q3 25 | $538.2M | $685.9M | ||
| Q2 25 | $553.8M | $636.9M | ||
| Q1 25 | $576.2M | $579.8M | ||
| Q4 24 | $589.3M | $612.7M | ||
| Q3 24 | $597.4M | $575.0M | ||
| Q2 24 | $602.9M | $543.9M | ||
| Q1 24 | $648.4M | $497.3M |
| Q4 25 | — | 15.87× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $183.5M |
| Free Cash FlowOCF − Capex | $16.1M | $175.0M |
| FCF MarginFCF / Revenue | 6.8% | 98.8% |
| Capex IntensityCapex / Revenue | 0.9% | 4.8% |
| Cash ConversionOCF / Net Profit | — | 3.16× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $326.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $183.5M | ||
| Q3 25 | $20.1M | $79.8M | ||
| Q2 25 | $4.2M | $42.0M | ||
| Q1 25 | $5.7M | $33.3M | ||
| Q4 24 | $24.2M | $148.8M | ||
| Q3 24 | $7.5M | $69.0M | ||
| Q2 24 | $82.4M | $17.5M | ||
| Q1 24 | $6.0M | $24.2M |
| Q4 25 | $16.1M | $175.0M | ||
| Q3 25 | $17.9M | $78.3M | ||
| Q2 25 | $2.3M | $40.8M | ||
| Q1 25 | $3.8M | $32.1M | ||
| Q4 24 | $21.7M | $132.0M | ||
| Q3 24 | $6.3M | $62.2M | ||
| Q2 24 | $79.6M | $12.8M | ||
| Q1 24 | $3.8M | $20.0M |
| Q4 25 | 6.8% | 98.8% | ||
| Q3 25 | 7.2% | 58.0% | ||
| Q2 25 | 0.8% | 34.1% | ||
| Q1 25 | 1.3% | 25.5% | ||
| Q4 24 | 7.0% | 79.9% | ||
| Q3 24 | 2.0% | 50.6% | ||
| Q2 24 | 23.4% | 10.9% | ||
| Q1 24 | 1.0% | 18.4% |
| Q4 25 | 0.9% | 4.8% | ||
| Q3 25 | 0.9% | 1.1% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 0.8% | 10.1% | ||
| Q3 24 | 0.4% | 5.5% | ||
| Q2 24 | 0.8% | 4.0% | ||
| Q1 24 | 0.6% | 3.9% |
| Q4 25 | — | 3.16× | ||
| Q3 25 | — | 7.61× | ||
| Q2 25 | — | 2.72× | ||
| Q1 25 | — | 71.84× | ||
| Q4 24 | — | 19.54× | ||
| Q3 24 | 2.92× | 16.60× | ||
| Q2 24 | — | 3.64× | ||
| Q1 24 | 2.23× | 11.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
GCMG
| Asset Management1 | $108.6M | 61% |
| Management Service Incentive Performance Fees | $61.7M | 35% |
| Management Service Incentive Carried Interest | $5.1M | 3% |
| Service Other | $1.8M | 1% |
